Sunday, January 23, 2022

Iran Ready to Tackle Biotechnology Sanctions: VP

More Articles

Avatar of IFP Editorial Staff
IFP Editorial Staff
The IFP Editorial Staff is composed of dozens of skilled journalists, news-writers, and analysts whose works are edited and published by experienced editors specialized in Iran News. The editor of each IFP Service is responsible for the report published by the Iran Front Page (IFP) news website, and can be contacted through the ways mentioned in the "IFP Editorial Staff" section.
Iran’s Vice President for Science and Technology Sorena Sattari says the country has specific plans to tackle sanctions, especially in the biotechnology sphere.

Iran will soon focus on a significant amount of support for medicine and vaccines needed for livestock and poultry, Sattari said during a visit to a knowledge-based company in the vicinity of Tehran.

He also announced the advancement of knowledge-based companies in biotechnology, human and animal medicine, and vaccines, adding that the young people who have ideas can, after a while, run knowledge-based companies and become a producer.

“We have great companies in this field, and we hope that this new move in the field of livestock and poultry will enable the country to be independent in producing medicines and vaccines,” said the vice president.

For a brief review of Iran’s achievements in various fields of science and technology, check the book “Science and Technology in Iran: A Brief Review – 2019

At the moment a good ecosystem has been created in this field turning the country into the first regional power in biotechnology, he added.

“We import $600 million worth of pharmaceuticals only in the human sphere annually, and we can produce 80 to 90 percent of it inside the country using the existing projects that are underway,” concluded Sattari.

Latest article